Xtandi (Enzalutamide) 40mg x 112 Soft Capsules

Product Description

Xtandi (Enzalutamide) 40mg x 112 Soft Capsules is a prescription medication used for the treatment of prostate cancer. It works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and spread of cancer cells in men with metastatic castration-resistant prostate cancer (mCRPC).

Indications

Xtandi is indicated for the treatment of:

• Metastatic castration-resistant prostate cancer (mCRPC)
• Non-metastatic castration-resistant prostate cancer (nmCRPC)

Dosage and Administration

The recommended dosage of Xtandi is 160 mg (four 40 mg soft capsules) taken orally once daily. It can be taken with or without food. It is important to swallow the capsules whole and not to chew or open them.

Side Effects

Common side effects of Xtandi may include:

• Fatigue
• Hot flashes
• Hypertension
• Diarrhea
• Nausea

Patients should report any severe side effects to their healthcare provider immediately.

Precautions

Before starting treatment with Xtandi, patients should inform their healthcare provider of any pre-existing conditions, especially:

• Seizure disorders
• History of heart problems
• Liver function impairment

Drug Interactions

Xtandi may interact with other medications. Patients should provide their healthcare provider with a complete list of all medications, supplements, and herbal products they are currently taking.

Storage

Store Xtandi at room temperature, away from moisture and heat. Keep out of reach of children.

Conclusion

Xtandi (Enzalutamide) offers a targeted approach to managing prostate cancer, providing patients with an effective treatment option. Always consult with a healthcare professional before starting any new medication.